Health

As an amendment to motion S4M-05654 in the name of Jackson Carlaw (Health), leave out from “potentially” to end and insert "for all aspects of access to new medicines are subject to an ongoing review; welcomes the introduction of the £21 million Rare Conditions Medicines Fund as an interim measure in response to advice by Professor Charles Swainson, who is undertaking the review of individual patient treatment request processes; accepts that routine approval of individual drugs is rightly a matter for the SMC and that, should the review highlight areas where these processes can be improved, these should be enacted quickly, and believes that the actual benefit to the patient and their quality of life must be the key consideration in determining the use of any new treatment or medicine and that the voices of patients and clinical experts must be heard in the assessment process."